A fetal liver kinase 1 (Flk‐1), as fusion proteins with the microbial adjuvant, LLO. Targeting the endothelial cells by Flk‐1 can induce the epitopes to spread to the endogenous tumor proteins, reduce the tumor micro‐vessel density, and cause tumor death. The gene discussed is KDR; the disease is neoplasm.